Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.04B 931M 869M 789M 1.49B 101B 1.5B 10.43B 4.08B 51.33B 3.92B 3.83B 165B P/E 2026 *
21.1x
P/E 2027 * 12.4x
Enterprise Value 2.53B 2.26B 2.11B 1.92B 3.61B 245B 3.64B 25.33B 9.91B 125B 9.51B 9.3B 401B EV / Sales 2026 *
1.52x
EV / Sales 2027 * 1.35x
Free-Float
72.32%
Yield 2026 *
-
Yield 2027 * -
1 day+3.15%
1 week-16.66%
Current month-17.63%
1 month-17.53%
3 months-22.49%
6 months+39.40%
Current year+7.97%
1 week 12.35
Extreme 12.35
13.51
1 month 12.35
Extreme 12.35
16.76
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
74.98
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 30/04/2026
Director of Finance/CFO 54 27/06/2023
Chief Tech/Sci/R&D Officer - 16/02/2026
Director TitleAgeSince
Chairman 64 02/01/2012
Director/Board Member 81 31/12/1991
Director/Board Member 65 31/12/2005
Date Insider Type Main position Quantity % Market Cap. Importance
17/09/26 Other

Company Secretary

26,838 0.0345%
01/09/26 Tax

Head of Human Resources

-1,455 0.0019%
03/07/26 Tax

Chief Financial Officer

-5,226 0.0067%
Change 5-day change 1-year change 3-year change Capi.($)
+3.15%-16.66%-9.45%-64.90% 1.04B
-0.24%+1.86%-26.65%+1.66% 170B
+2.62%+1.52%-10.34%+15.28% 112B
+0.57%+1.47%-26.20%+4.18% 106B
-2.49%-1.11%-48.69%-12.84% 73.6B
+1.29%+3.73%+3.46%+74.79% 61.32B
-0.52%+3.00%+11.98%+64.88% 52.89B
+1.44%+2.63%-5.76%-30.36% 49.78B
+1.28%-0.89%-18.54%+15.06% 40.43B
+0.13%-2.11%+24.54%+1.43% 31.85B
Average +0.73%-0.10%-10.57%+6.92% 69.98B
Weighted average by Cap. +0.45%+1.81%-16.42%+12.28%

Financials

2026 *2027 *
Net sales 1.66B 1.48B 1.38B 1.26B 2.37B 161B 2.39B 16.63B 6.5B 81.81B 6.24B 6.11B 263B 1.72B 1.53B 1.43B 1.3B 2.45B 166B 2.47B 17.19B 6.72B 84.57B 6.45B 6.31B 272B
Net income 49.25M 43.98M 41.03M 37.27M 70.13M 4.77B 70.82M 493M 193M 2.42B 185M 181M 7.8B 78.69M 70.27M 65.56M 59.55M 112M 7.62B 113M 787M 308M 3.87B 295M 289M 12.46B
Net Debt 1.49B 1.33B 1.24B 1.13B 2.12B 144B 2.14B 14.9B 5.83B 73.3B 5.59B 5.47B 236B 1.28B 1.15B 1.07B 972M 1.83B 124B 1.85B 12.85B 5.03B 63.24B 4.82B 4.72B 203B
Projected Income Statement - Annual - Integra LifeSciences Holdings Corporation
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
08/10/26 US$13.41 +3.15% 1,459,658
07/10/26 US$13.00 -2.40% 1,408,453
06/10/26 US$13.32 +0.23% 1,370,157
05/10/26 US$13.29 +4.81% 1,859,001
02/10/26 US$12.68 -21.19% 2,695,971
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - Integra LifeSciences Holdings Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
13.41USD
Average target price
18.38USD
Spread / Average Target
+37.02%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Integra LifeSciences Holdings Corporation
  1. Stock Market
  2. Stocks
  3. IART Stock